| Jun 14 |
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
| Jun 13 |
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
|
| Jun 6 |
MicroCap Rodeo’s Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies
|
| Jun 4 |
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
|
| Jun 3 |
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
|
| May 22 |
Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
|
